Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Business Model:
Revenue: $11.5M
Employees: 51-200
Address: Level 1 120 Jolimont Road
City: East Melbourne
State: victoria
Zip: 3002
Country: AU
Starfish Ventures is a venture capital firm. That specializes in seed, start-up, expansion, emerging growth, early venture, mid venture, late venture, growth capital, middle market, and buyouts investments. The company prefers to invests in life sciences, clean technology, materials science, and information technology. Within life sciences, it focuses on biotechnology, medical devices, therapeutics, and drug development. Within clean technology, the firm invests in energy, water, and other environmental technologies. Within information technology, it considers investments in software, mobile, Internet and cloud based enterprise systems, semiconductor, instrumentation, hardware, and telecommunications. It seeks to exit its investments through mergers and acquisitions, trade sale, or an initial public offer within two to five years. Starfish Ventures was founded by John Dyson and Michael Panaccio in 2001, and is headquartered in Melbourne, Australia.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2006 | Protagonist Therapeutics | Series A | 9M |
6/2008 | Aruspex | Series A | 3.8M |
10/2012 | MetaCDN | Series A | 2.3M |
3/2008 | Holly Connects | Venture Round | - |
4/2005 | Distra | Venture Round | 3.9M |
12/2008 | DorsaVI | Seed Round | - |
6/2008 | Audinate | Series A | 0 |
2/2008 | Monitoring Division | Series A | 3.9M |
1/2012 | BugHerd | Venture Round | 550k |
10/2013 | Nitro | Unattributed | 3.1M |
9/2013 | Ourcast | Seed Round | 200k |
6/2012 | Bubble Gum Interactive | Series B | 2.5M |
11/2007 | Austhink Software | Series B | 3.8M |
6/2013 | Aktana | Series A | 5.5M |
11/2011 | DesignCrowd | Series A | 3M |
1/2010 | Audinate | Venture Round | 0 |
2/2015 | DesignCrowd | Series B | 4.7M |
6/2013 | Protagonist Therapeutics | Series B | 0 |
6/2008 | 5th Finger | Series A | 7M |
5/2012 | Scalify | Series A | 2M |
3/2009 | Ofidium | Series A | 6M |
3/2010 | Evostor | Series A | 3M |
11/2008 | Evostor | Series A | 5M |
3/2006 | Qs Semiconductor Corporation | Venture Round | 1.3M |
4/2012 | Nitro | Series A | 3.5M |
5/2012 | Aktana | Series A | 2M |
12/2006 | Quickcomm Software Solutions | Series A | 4.1M |
10/2012 | StreamShark | Series A | 2.3M |
3/2005 | G2 Microsystems | Series A | 0 |
9/2005 | Engana Pty | Series B | 0 |
8/2014 | BugHerd | Series A | 929.6k |
11/2006 | Intersection Medical Inc | Series B | 5M |
5/2011 | Ourcast | Seed Round | 1.3M |
8/2019 | Marani | Seed Round | 0 |
8/2006 | ImpediMed | Venture Round | 3.4M |
10/2010 | ICIX | Series B | 6M |
2/2021 | DesignCrowd | Venture Round | 7.6M |
11/2006 | Impedance Cardiology Systems | Series B | 5M |
6/2016 | Aktana | Series B | 17.6M |
7/2006 | G2 Microsystems | Series B | 14M |
1/2012 | BugHerd | Seed Round | 550k |
3/2012 | StyleTread | Series C | 12.4M |
1/2009 | ZoomSystems | Series E | 0 |
1/2007 | MuriGen | Series A | 3.9M |
6/2012 | UpGuard | Seed Round | 1.2M |
4/2009 | Ausra | Venture Round | 25.5M |
7/2015 | Protagonist Therapeutics | Series C | 0 |
2/2004 | Xelor Software | Series A | 4.7M |
9/2005 | Xelor Software | Series B | 6M |
10/2012 | Ourcast | Venture Round | 500k |
11/2012 | Atmail | Venture Round | 2M |
8/2011 | Aktana | Series A | 3M |
2/2021 | DesignCrowd | Venture Round | 0 |
8/2019 | Marani | Seed Round | 0 |
6/2016 | Aktana | Series B | 0 |
7/2015 | Protagonist Therapeutics | Series C | 0 |
2/2015 | DesignCrowd | Series B | 0 |
8/2014 | BugHerd | Series A | 0 |
10/2013 | Nitro | Series A | 0 |
9/2013 | Ourcast | Seed Round | 0 |
6/2013 | Aktana | Series A | 0 |
6/2013 | Protagonist Therapeutics | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|